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Background: The stentless porcine aortic root prosthesis (SPAR) has been described as a suitable valve 
for right ventricular outflow tract reconstruction (RVOTR). Our institution began using this valve for 
RVOTR in 1998. Herein we report our medium to late term outcomes of the valve in the pulmonary 
position. 
Methods: A retrospective chart review was conducted of patients over 18 years old who underwent 
RVOTR with the SPAR between April 2000 and October 2019. Primary outcomes included survival and 
freedom from any valvular re-intervention. Secondary outcomes included endocarditis and conduit 
dysfunction obtained from routine echocardiography and/or cardiac MRI.  
Results: A total of 135 patients underwent RVOTR with a SPAR at a median age of 32.4 (range 18-71). 
129 had previous surgery. Indications included pulmonary insufficiency (90.4%), stenosis (34.8%), 
endocarditis (7.4%) and carcinoid (4.4%). Median follow-up was 2.97 years (IQR 0.6-8.0). Overall 
survival was 93.3%, with 3 perioperative and 6 late deaths. Four (2.9%) developed endocarditis, two of 
which required reoperation. Progressive conduit degradation was evident at 10 years with 22.2% and 
7.7% moderate stenosis and insufficiency. Eight (5.9%) re-interventions included 2 surgical replacements, 
3 percutaneous replacements and 3 balloon valvuloplasties at means of 8.5, 7.4 and 2.2 years, 
respectively. Overall freedom from re-intervention at 1, 5, 10 years was 99.1%, 94.7% and 90.7%, 
respectively. 
Conclusions: In one of the largest single institution experiences with adults, with one of the longest 
follow-up periods, this usage of the SPAR demonstrates excellent mid-to-long term durability, low rates 
of endocarditis, and high freedom from re-intervention. 




Right ventricular outflow tract (RVOT) procedures are among the most common surgical 
procedures performed for adults with congenital heart disease (ACHD).1 A wide variety of pulmonary 
valve replacement options exist, and there is significant heterogeneity in congenital cardiac surgical 
program preferences. The stentless porcine aortic root (Freestyle, Medtronic Inc., Minneapolis, MN) was 
initially developed for aortic root replacement, but has gradually gained wider acceptance for pulmonary 
valve replacement (PVR) over the past two decades based on its favorable hemodynamic profile. Since 
2000, we have preferentially used the Freestyle stentless porcine aortic root for PVR and RVOT 
reconstruction in patients 18 years and older.  
Possible advantages of the stentless porcine valve include its wider size availability and 
maintenance of laminar flow in an orthotopic position. The primary disadvantage is the more involved 
surgical technique with the need to fully mobilize the main pulmonary artery and RVOT. Despite this 
added difficulty with surgical placement of the stentless porcine aortic root, numerous studies have 
demonstrated excellent short-to-medium term outcomes and rates of endocarditis ranging from 0-5%. 2-7 
In this study, we aimed to evaluate medium-to-long term outcomes including valve durability and 
need for re-intervention following stentless porcine PVR for older adolescent and adult patients at our 
institution. 
 
Material and Methods 
Patient Selection 
All patients 18 and older at the time of pulmonary valve replacement between April 2000 and 
October 2019 were retrospectively identified from hospital databases at Indiana University Methodist 
Hospital and Riley Hospital for Children at Indiana University Health. Patients who underwent placement 
of a stentless porcine aortic root in the right ventricular position were included. Selection was based on 
surgeon’s preference and anatomical suitability and patients were not consecutive. The databases were 
queried for index operative details as well as follow up details including echocardiographic and cardiac 
magnetic resonance imaging (MRI) data, last follow up date, and death information. 
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Death and freedom from re-intervention were the primary endpoints. Secondary endpoints 
included conduit dysfunction and endocarditis. Peak and mean conduit gradients were determined by 
standard echocardiography. Conduit regurgitation was graded as none, trivial/trace/mild (grouped into 
one category), moderate and severe. 
Conduit dysfunction was defined as moderate or greater insufficiency or a peak gradient >36mm 
Hg, consistent with moderate pulmonic stenosis based on American Heart Association guidelines.8  
Patients who underwent catheter-based intervention (balloon valvuloplasty or percutaneous valve 
replacement) or surgical valve replacement were considered intervened upon, and concluded in the study. 
In the situation of a patient undergoing replacement with another porcine aortic root, a new patient entry 
into the database was created. Follow-up data were gathered from the most recent clinical assessment by a 
member of the heart team. To minimize heterogeneity, specific time intervals were studied.  
 
Operative Technique 
Cardiopulmonary bypass was performed with bi-caval cannulation and mild-moderate 
hypothermia (32-34oC). A transesophageal echocardiogram is performed prior to cardiopulmonary bypass 
to assess for a patent foramen ovale (PFO) or atrial septal defect (ASD). If no PFO/ASD is present, 
frequently we performed PVR without arrest at normothermia with the patient in Trendelenberg position 
and the aortic root vented in the event that a small shunt was missed on bubble study. For the PVR, the 
main pulmonary artery is incised then mobilized circumferentially to the bifurcation. The main pulmonary 
artery is transected and excised to the level of the infundibulum. If a transannular patch is present, we do 
not excise it entirely if it is not aneurysmal and include it in the proximal anastomosis. The RVOT is 
inspected for muscle bundles or other obstructions. The porcine aortic root is rinsed and prepared 
according to manufacturer instructions. We orient the porcine aortic root such that one coronary stump 
faces leftward and the other anteriorly. This positions one commissure directly posteriorly and midline. 
Typically, a small wedge is resected from the distal edge of the conduit to minimize length. (Figure 1) 
The distal anastomosis is constructed with a 4-0 or 5-0 polypropylene suture in continuous fashion after 
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aligning the frenulum at the distal bifurcation with the posterior conduit commissure. If the infundibular 
region is aneurysmal, resection or plication is performed. Conversely, augmentation of the infundibulum 
with a bovine pericardial patch is used when the proximal anastomosis appears to be constricted. The 
proximal anastomosis is fashioned using a continuous 3-0 or 4-0 polypropylene suture. The coronary 
stumps of the conduit must be inspected as they frequently are not fully hemostatic and additional ties 
may be needed to secure them. For all conduit replacement procedures, we reconstruct the pericardium 
with a 0.1 mm expanded polytetrafluoroethylene patch (W. L. Gore & Associates, Flagstaff, AZ). 
 
Statistical Methods 
Univariate analysis was used in the full sample (n=135) to describe the population. In addition, 
the median length-of-stay was compared between groups undergoing isolated pulmonary valve 
replacement against those with concomitant procedures with the student’s t-test. Kaplan-Meier (KM) 




A total of 135 patients underwent 137 right ventricular outflow tract reconstructions with a 
porcine aortic root during the study period. Demographics are listed in Table 1. The median age was 32.4 
years and a slight majority was male. Tetralogy of Fallot, pulmonary atresia, and pulmonary stenosis were 
the most common underlying primary diagnoses (Table 1). Only 6 patients had no prior sternotomy, all of 
whom had metastatic carcinoid syndrome with right heart dysfunction. Ten previous Ross patients 
underwent PVR as a replacement for the homograft implanted at the initial Ross operation. The majority 
(94%) of patients had previous RVOT intervention including 53 (39.2%) with a right ventricular conduit 
(consisting of non-valved conduits, bovine jugular venous conduit, homograft, Freestyle porcine aortic 




The most common indication (90%) for PVR was insufficiency of the existing conduit or native 
pulmonary valve, followed by pulmonary valve or conduit stenosis and right ventricular dilation and/or 
dysfunction. Associated diagnoses included atrial arrhythmia, moderate or greater tricuspid insufficiency, 
atrial septal defect and ventricular septal defect. Notably, 10 patients had active pulmonary prosthetic 
endocarditis at the time of operation, with none re-infecting the new SPAR, though one died in the 
perioperative period (Table 2). 
Table 3 lists the multitude of concomitant procedures performed in over 60% of patients. The 
most common concomitant procedures included pacemaker insertion/revision and RVOT revisional 
procedures (muscle bundle division, aneurysm plication, or infundibuloplasty with bovine pericardial 
hood augmentation). Utilization of a right atrial MAZE procedure increased later in the series. Tricuspid 
valve replacement was required in a small subset of patients. Performance of concomitant procedures was 
associated with a longer hospital length-of-stay (p<0.0003; Table 3). The most common size of porcine 
aortic root was 27 mm which was used in over half of the group (Figure 2). Over 90% of the group 
received a conduit 25 mm or larger. Interestingly, two early patients under 10 years of age received 19 
mm and 21 mm porcine aortic root, and subsequently underwent re-replacement as adults, at intervals of 
15 and 19 years, respectively. These were not included in the durability and re-intervention data due to 
age exclusions, but their second PVR procedures were. 
 
Survival 
Overall survival for the entire group was 93% (Table 4). Three deaths occurred in the immediate 
perioperative period as a result of multisystem organ failure. Three other mortalities within the first year 
were due to hepatic dysfunction, metastatic carcinoid tumors or unknown etiology. Overall, two of the six 
metastatic carcinoid tumor patients died. There were no deaths between 1 and 5 years. Three late deaths 
occurred (5, 7 and 11.5 years postop). The death at five years was a patient undergoing repeat PVR for 
porcine root endocarditis with pseudoaneurysm and died in the perioperative period, and remains unique 
to our experience due to the complications and mortality. The other two deaths were due to pneumonia-
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related complications. None of the PVR-only patients died in the early or late period. Figure 3 displays 
the Kaplan-Meyer curve for overall survival, which at 1, 5, 10 and 14.5 years was 94.5%, 93.2%, 90.8% 
and 79.5%, respectively. 
Twenty-four patients (17.7%) experienced a total of 46 complications within 90 days of operation 
(Table 4). Six patients required early mediastinal exploration for postoperative hemorrhage or tamponade. 
Six additional mediastinal complications after 30 days and included pericardial effusion and mediastinal 
infection. Rhythm related complications (atrial fibrillation and atrial flutter) were the most common in our 
series. Pulmonary complications included prolonged mechanical ventilation, pleural effusion, and 
pneumothorax requiring tube thoracostomy. 
 
Reintervention 
There were a total of 8 porcine aortic root interventions during the study period occurring at a 
mean interval of 5.7 years. Six patients developed stenosis requiring intervention. Three patients 
underwent early balloon valvuloplasty at 1, 1.8 and 4 years, but required no further intervention. Three 
patients underwent transcatheter pulmonary valve replacement at 5, 6.4, and 10.9 years. Four patients 
developed endocarditis of the porcine aortic root, and two of these required eventual surgical replacement 
at 5 and 12 years (with porcine aortic roots). Figure 3 displays the Kaplan-Meyer curve for porcine aortic 
root intervention. The freedom from re-intervention (transcatheter or surgical) at 1, 5, and 10 years was 
99.1%, 94.7%, and 90.7% respectively.  
 
Conduit Performance  
Echocardiograms were routinely collected perioperatively and during postoperative years 1 
(Early), 3-5 (Middle) and 8-10 (Late;Table 6). One echocardiogram per patient during each time period 
was chosen as some patients underwent multiple studies in a short time interval. Initial hemodynamics 
were excellent in terms of conduit gradients. 52% had no regurgitation, 24% trace, and 24% mild 
insufficiency in the perioperative period.  As Table 6 and Figure 4 illustrate, there were progressive, 
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linear increases without plateau in these parameters over the study period. At one year, no patients had 
moderate PI, and nine had moderate-or-greater PS. Two patients required balloon valvuloplasty. By the 
Middle interval of 3-5 years,, ten patients developed moderate-or-greater PS requiring two interventions: 
one balloon valvuloplasty and one transcatheter valve replacement. One patient who had undergone early 
balloon valvuloplasty developed moderate PI in this interval. By the late postoperative period  PS 
increased to a median peak gradient of 27 mmHg, though carrying a low re-intervention rate and 30.7% 
exhibited no PI and 61.5% developed trace to mild PI. More recently, patients have been followed with 
cardiac MRI. Twenty–nine patients at a median 2.5 years (IQR 1.5-4.8) postoperatively had an 
RVEDV:LVEDV ratio of 1.2 (IQR 1.0-1.5) and a pulmonary artery regurgitation fraction of 5% or less.  
 
Endocarditis 
Ten patients (7.4%) underwent placement of the porcine root with active endocarditis; two 
patients with an infected porcine aortic root and eight with various other prostheses. None of the ten 
infected the new prosthesis and antibiotics were discontinued at six weeks beyond surgery. One of the ten 
died in the postoperative period following replacement. Of the study group, four patients (2.9%) 
developed endocarditis. Two patients were able to clear the bacteremia and did not require any 
reintervention, while the aforementioned two required replacement with a SPAR. 
 
Comment 
This study represents the largest and among the longest follow up single center experience with 
right ventricular outflow tract reconstruction using the porcine aortic root in patients 18 years of age. This 
nearly twenty-year experience provides insight into the intermediate-to-late term outcomes of the use of 
the porcine aortic root in the pulmonary position with favorable durability and patient outcomes.  
The first porcine aortic root PVR procedures were performed at our institution in 1998 and 2000 
for adult usage, however, these occurred sporadically. The porcine aortic root became increasingly 
utilized after 2003 and we now perform 10-15 porcine aortic root PVR procedures annually, almost 
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exclusively in adult patients. This trend of increased and preferred usage has decreased the median follow 
up and accordingly, comparison with our bioprosthetic valve replacement options was not possible. The 
authors recognize that the increased recent usage has decreased the study’s median time points, however 
the large population with data extending beyond five and ten years provide insight into the true durability 
of the conduit. 
 
Survival 
Overall survival in this series was excellent and comparable to other published reports.2,9-11 
However, there is considerable variability in patient cohorts, number of patients studied, and length of 
follow-up across studies. In a similar study to our own, Dunne et al. retrospectively reviewed all porcine 
aortic root PVRs in 114 patients with congenital heart disease at a single institution with a median age of 
21 years, and reported a survival rate of 91% at 10 years and overall.7 In  study comparing several 
different bioprosthetic valves in the pulmonary position (n=181), including the porcine aortic root (n=23), 
Lee et al reported an overall survival of 93.7% at 10 years.12 Our study supports the literature which 
demonstrates that the porcine aortic root is a safe option for surgical PVR with excellent rates of survival 
approaching long-term periods of follow-up.  
 
Reintervention 
Perhaps the most remarkable finding of the present study is the low rate of re-intervention. At 1, 
5, and 10 years, the freedom from re-intervention was 99.1%, 94.7% and 90.7%, respectively. Other 
studies report similar rates of freedom from re-intervention at 5 years: 95.5% (Hawkins et al), 93.2% 
(Kuo et al), and 85% (Dunne et al). 2,4,7 However, the results of our study dramatically diverge from the 
literature at 10 years with rates of freedom from re-intervention dropping to 71% (Dunne et al), 48.4% 
(Kuo et al), and 31.2% (Lee et al). 4,7,12 One possible explanation for this difference is patient age at the 
time of operation. While the median age of the above studies ranged from 12.2 to 21 years, the median 
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age of our patients was 32.4 years, with the youngest patient being 18 years of age. Our study did not 
include metrics of body size, and correlating conduit and patient size may be of future interest. 
 
Structural Valve Degeneration  
We observed progressive, linear changes in conduit stenosis and regurgitation throughout the 
study period without an obvious plateau. However, the rate of re-intervention did not seem to correlate yet 
with these patterns. Similar to our results, other studies have demonstrated low early rates of structural 
valve degeneration which tend to increase over time.7, 10, 11, 15  Dunne et al reported that at 18 months 
follow-up only 3.5% of patients had signs of moderate pulmonary stenosis and/or regurgitation.7 By 5 and 
10 years, only 82% and 61% of patients were free from significant valve degeneration, respectively.7,15 Of 
the patients with structural valve degeneration, half were attributed to pulmonary stenosis, 12.5% to 
pulmonary regurgitation, and 16.7% to both.7,15 Other recent single institution reports have found that the 
porcine aortic root compares comparably favorably with pulmonary homografts in terms of conduit 
durability at up to 10 years of follow-up.5,6 What remains to be seen is whether the trajectory of conduit 
dysfunction changes over time and whether patients will face an increasing likelihood of conduit re-
intervention. The early cardiac MRI data for more recent patients in this study indicate favorable conduit 
performance with positive RV remodeling, although more longitudinal follow-up for more patients is 
necessary. Regardless, with an adequately sized porcine aortic root (e.g., >23 mm), transcatheter 
pulmonary valve replacement should remain a viable option for these patients especially since the porcine 
aortic root is resistant to late dilatation. 
 
Endocarditis  
Other studies also report very low rates of stentless porcine aortic root endocarditis, with 
incidences ranging from 0% to 5.4%.7,11-14 Multiple series report using the stentless porcine aortic root in 
aortic valve or aortic root endocarditis, but to our knowledge, this series represents the first reporting for 
of the use of this conduit in active RVOT endocarditis. Our study rates of endocarditis in the present 
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study are comparable to contemporary RVOTR studies, but when considering the usage in active 
endocarditis without subsequent reinfection, these results are very favorable. It is unclear why the porcine 
aortic root is associated with a comparatively low rate of endocarditis, but we hypothesize that orthotopic 
positioning of the conduit facilitates more laminar flow than stented bioprostheses. 
 
Study Limitations 
Our study is inherently limited by its design as a retrospective, single-institution study. Nearly all 
operations were performed, at least in part, by a single surgeon which may limit the generalizability of 
this study to other institutions.  Patient management spanned over a 19-year period, and era effects may 
not have been fully characterized. Certain aspects of the surgical procedures (e.g., cardiopulmonary 
bypass variables) and follow-up data (e.g., cardiac MRI) were not consistently available across the study 
period. There was no direct comparison with other bioprosthetic valves. 
 
Conclusion 
Pulmonary valve replacement using the porcine aortic root in adults can be performed safely and 
effectively with excellent mid-to-long term durability, low rates of endocarditis, and high freedom from 
re-intervention. Should re-intervention be required, the porcine aortic root can usually accommodate 
percutaneous valve replacement. Future multi-institutional studies may be necessary to effectively 
compare various prosthetic PVR options and longitudinal follow-up will be important for understanding 
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Table 1. Patient Demographics (N=135). 
Demographic N (%) 
Age at implant, years 
 
    Median 32.4 
    Range 18-71 
Sex 
 
    Male 70 (51.8%) 
    Female 65 (48.2%) 
Follow-up (years) 
 
   Median, IQR  2.97 (0.6-8.0) 
   Range 0-14.5 
Primary Diagnosis  
  Tetralogy of Fallot 66 (48.9%) 
  Pulmonary atresia 25 (18.5%) 
  Pulmonary stenosis 11 (8.1%) 
  Aortic stenosis status post Ross         
procedure 
10 (7.4%) 
  Double-outlet right ventricle 6 (4.4%) 
  Carcinoid syndrome 6 (4.4%) 
  Truncus Arteriosus 5 (3.7%) 
  Transposition of the great arteries 4 (3.0%) 
  Absent pulmonary valve 2 (1.5%) 
Prior Sternotomy 129 (95.6%) 
Prior RVOT Interventions 127 (94.0%) 
  RVPA Conduit  53 (39.2%) 
     Non-valved conduit 16 (11.8%) 
     Monocusp repair                      11 (8.1%) 
     Homograft 10 (7.4%) 
     Other PVR 10 (7.4%) 
     Bovine jugular venous conduit   6 (4.4%) 
  Other Tetralogy repair 38 (26.6%) 
  Transannular patch 32 (23.7%) 
  Surgical valvotomy  12 (8.8%) 
  Rastelli procedure 8 (5.9%) 





Table 2. Pulmonary valve replacement indications. 
Operative Indications  N (%) 
Pulmonary/conduit insufficiency 122 (90.4) 
Pulmonary/conduit stenosis 47 (34.8) 
RV dilatation/dysfunction 32 (23.7) 
Endocarditis 10 (7.4) 
Carcinoid syndrome 6 (4.4) 
Additional Diagnoses 
 ASD/PFO 
 Atrial arrhythmia 
 Moderate or severe tricuspid insufficiency 





ASD, atrial septal defect; PFO, patent foramen ovale. 
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Table 3. Concomitant Procedures 
 None 51 (37.7) 
 At least one 84 (63.3) 
 1       46 (34.0) 
 2  21 (15.5) 
 3 or more 17 (11.1) 
 Pacemaker- elated 21 (15.6) 
 RVOT revision 25 (18.5) 
 RVMB division 11 (8.1) 
 Infundibular patch revision 7 (5.2) 
 Right ventriculoplasty 6 (4.4) 
 Aneurysm plication 3 (2.2) 
 Infundibulopasty 2 (1.5) 
 MAZE procedure 17 (12.6) 
 ASD/PFO closure 15 (11.1) 
 Tricuspid repair/replacement 13 (9.6) 
 Pulmonary artery patch angioplasty 12 (8.9) 
 Aortic valve/root procedures 11 (8.1) 
 Right atrioplasty 7 (5.2) 
 VSD closure 5 (3.7) 
 Pulmonary artery stent removal 5 (3.7) 
 Coronary artery bypass 3 (2.2) 
 Ascending aorta replacement 3 (2.2) 
 Warden procedure 1 (0.7) 
 SVC reconstruction 1 (0.7) 
Median Length-of-stay (days) 7.3 (0-31) 
 LOS, PVR only 5 (IQR 4-6) 
 LOS, concomitant procedures 7 (IQR 5-10) 
ASD, atrial septal defect; IQR, interquartile; LOS, length-of-stay; 
PFO, patent foramen ovale; RVMB, right ventricular muscle 
bundle; SVC, superior vena cava; VSD, ventricular septal defect. 
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Table 4. Survival and complications. 
Survivors, n (%) 126 (93.3) 
     Carcinoid survival 4 (66.7) 
Total Deaths 9 (6.7) 
 Early (<30 days) 3 (2.2) 
 <1 year carcinoid death 2 (1.5) 
 Intermediate (30 days-5 years) 3(2.2) 
     Late (>5 years) 3 (2.2) 
Total Early Complications 46 (34.1) 
 Rhythm disturbance 11 (8.1) 
 Pulmonary (prolonged ventilation, effusion, pneumothorax) 7 (5.2) 
 Mediastinal  
 Early (<30 days, hemorrhage, tamponade) 6 (4.4) 
 Delayed (>30 days, effusion, mediastinal infection) 6 (4.4) 
 Others (vocal cord paralysis, pancreatitis, right heart failure, 
decubitus ulcer, opiate intoxication) 
6 (4.4) 
 Multisystem organ failure 5 (3.7) 
 Renal Failure 5 (3.7) 
IQR, interquartile range; PVR, pulmonary valve replacement. 
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Table 5. Pulmonary valve re-interventions. 
Re-intervention N (%) Median Interval (years) 
 Total re-interventions 8 (5.9) 5.0 (IQR 3.4-7.5) 
 Balloon valvuloplasty 3 (2.2) 1.9 (IQR1.4-2.9) 
 Percutaneous replacement 3 (2.2) 6.4 (IQR 5.7-7.9) 
 Surgical replacement 2 (1.5) 8.5 (IQR 6.8-10.3) 
IQR, interquartile range 
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Table 6. Echocardiographic follow-up. 
Period Perioperative  Early Middle  Late 
Number of studies 104 77 58 44 
Median time  
  (IQR) 
13 days 
  (3-39) 
1.1 years 



























2 (2.4%) 8 (11.8%) 8 (17.8%) 8 (22.2%) 
Moderate PI 1 (1.8%) 0 (0%) 1 (2.1%) 2 (7.7%) 
Re-interventions (%) 0 2 (2.5) 3 (5.1) 2 (4.5) 
IQR, interquartile range; PI, pulmonary insufficiency; PS, pulmonary stenosis. 
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Figure Legends 
Figure 1. (Left) The porcine aortic root with small wedge excision above the posterior commissure. 
(Right) Orthotopic positioning of the porcine aortic root aligns the coronary stumps anteriorly and 
leftward. An infundibuloplasty was performed inferior to the conduit. 
Figure 2. Porcine aortic root available sizes and usage within the study population. N=135 
Figure 3. (Top) Overall survival for all adult patients with the porcine aortic root in pulmonary position. 
Survival at 1, 5, 10, and 14.5 years was 94.5%, 93.2%, 90.8% and 79.5%. (Bottom) Overall freedom from 
re-intervention (balloon valvuloplasty, transcatheter or open surgical replacement) for all adult patients 
with the porcine aortic root in pulmonary position. Freedom from re-intervention at 1, 5, and 10 years was 
99.1%, 94.7%, and 90.7%. 
Figure 4. Echocardiographic data perioperatively and at Early, Middle and Late intervals. Peak conduit 
gradients of >36mm Hg represent moderate stenosis. 




